Stephens & Co. Reiterates Overweight on Dorman Products, Maintains $150 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 78.2%

Neg 0% Neu 78.2% Pos 0%

Stephens & Co. analyst Jeff Lick reiterates Dorman Products (NASDAQ:DORM) with a Overweight and maintains $150 price target.